PARP-Targeted Auger Therapy in p53 Mutant Colon Cancer Xenograft Mouse Models.

Wilson T, Pirovano G, Xiao G, Samuels Z, Roberts S, Viray T, Guru N, Zanzonico P, Gollub M, Pillarsetty NVK, Reiner T, Bargonetti J. PARP-Targeted Auger Therapy in p53 Mutant Colon Cancer Xenograft Mouse Models. Mol Pharm. 2021 09 06; 18(9):3418-3428.

View in: PubMed

subject areas

Animals
Cell Line, Tumor
Colonic Neoplasms
Electrons
Female
Humans
Mice
Phthalazines
Piperazines
Tumor Suppressor Protein p53
Xenograft Model Antitumor Assays

authors with profiles

Jill Bargonetti

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support